PMID: 2872388Apr 1, 1986Paper

Presynaptic beta-adrenoceptors

Medicinal Research Reviews
Y Misu, T Kubo


The existence of facilitatory presynaptic beta-adrenoceptors has been shown in approximately 30 tissues of 6 different species including human. A positive feed back loop for further release of the transmitter appears to be activated by an endogenous agonist, epinephrine, taken up and released as a cotransmitter with norepinephrine rather than norepinephrine itself released from peripheral noradrenergic nerve terminals. Presynaptic beta-adrenoceptors are mainly of a beta 2-subtype. Some beta 1-subtype receptors are also suggested. There coexist presynaptic beta 1- and beta 2-adrenoceptors in cat and rat hypothalamus. Higher sensitivity of peripheral presynaptic beta-adrenoceptors to isoproterenol may be implicated in the early development of hypertension in SHR. Epinephrine taken up and released initiates the development of hypertension in rats via activation of these receptors. Increased activation of these receptors by epinephrine may play a role in the development of essential hypertension. The antihypertensive action of beta-antagonists may be in part due to blockade of these facilitatory presynaptic beta-adrenoceptors.


Mar 1, 1976·Acta Physiologica Scandinavica·L Stjärne, J Brundin
Mar 1, 1976·The Journal of Pharmacy and Pharmacology·I E Hughes, B Kneen
Dec 1, 1976·Drugs·H J Waal-Manning
Jan 1, 1977·Reviews of Physiology, Biochemistry and Pharmacology·K Starke
Sep 1, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·H D TaubeE Borowski
Apr 1, 1979·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·W G WoodP C Scriba
Apr 26, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·A Philippu, E Kittel
Apr 26, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·P Boonyaviroj, Y Gutman
Oct 1, 1977·Physiological Reviews·T C Westfall
Feb 1, 1979·Biochimica Et Biophysica Acta·C J Limas, C Limas
Apr 1, 1975·British Journal of Pharmacology·P M Dawes, D C Faulkner
Feb 1, 1975·Japanese Journal of Pharmacology·K TakedaS Imai
Jun 20, 1975·Naunyn-Schmiedeberg's Archives of Pharmacology·U OttenH Thoenen
Nov 12, 1977·British Medical Journal·R Franco-MorselliP Meyer
Nov 1, 1978·Naunyn-Schmiedeberg's Archives of Pharmacology·S GuimarãesM Q Paiva
Feb 1, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·T EndoH D Taube
Mar 1, 1973·The Journal of Pharmacy and Pharmacology·E J Mylecharane, C Raper
Jan 1, 1974·Naunyn-Schmiedeberg's Archives of Pharmacology·K H RahnG Planz
Apr 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·M J Peach
Mar 1, 1974·The Journal of Physiology·S D Jaanus, R P Rubin
Dec 1, 1968·The Journal of Pharmacy and Pharmacology·M D DayP R Warren
Aug 1, 1970·The Journal of Pharmacy and Pharmacology·B AbladB Waldeck
Nov 1, 1970·The Journal of Pharmacy and Pharmacology·A M Barrett, B Nunn
Jul 1, 1973·The Journal of General Physiology·G R Strichartz
Jul 1, 1971·British Journal of Pharmacology·O D Gulati, S Jaykar
Jun 1, 1984·Cellular and Molecular Neurobiology·W G Shain, D L Martin
Sep 1, 1980·Clinical and Experimental Pharmacology & Physiology·I C MedgettD F Story
Jan 9, 1982·Lancet·A J Smith, R F Bing
Sep 24, 1982·European Journal of Pharmacology·M J StevensR F Moulds
Feb 12, 1983·Lancet·M A SchalekampA J Man In't Veld
Jan 1, 1983·General Pharmacology·R F Moulds, M J Stevens
May 15, 1983·Biochemical Pharmacology·E J Ariëns, A M Simonis
Sep 30, 1983·European Journal of Pharmacology·M L SteenbergM F Lokhandwala
Jun 1, 1983·British Journal of Pharmacology·D A Brown, P M Dunn
Nov 25, 1983·European Journal of Pharmacology·D Hovevei-SionM B Youdim
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·M J Brown, C T Dollery
Aug 17, 1984·European Journal of Pharmacology·K R Borkowski, P Quinn
Jan 1, 1981·Journal of Cardiovascular Pharmacology·H MajewskiM J Rand
Jan 1, 1982·Journal of Cardiovascular Pharmacology·H MajewskiM J Rand
Nov 1, 1982·Journal of Cardiovascular Pharmacology·E Adler-Graschinsky, A H Carrara
Jul 1, 1984·Journal of Cardiovascular Pharmacology·H H SchmidtH Majewski
Jan 1, 1980·British Journal of Pharmacology·H MajewskiD F Story
Jan 1, 1981·Annual Review of Pharmacology and Toxicology·K Starke
Feb 19, 1981·European Journal of Pharmacology·H Majewski, M J Rand
May 1, 1982·British Journal of Clinical Pharmacology·H H VincentM A Schalekamp
Jun 1, 1984·Biochemical Pharmacology·M L Michener, M J Peach
Oct 1, 1982·Naunyn-Schmiedeberg's Archives of Pharmacology·H MajewskiK Starke
Feb 1, 1980·Clinical and Experimental Hypertension : CHE·N D VlachakisR F Maronde
May 9, 1964·British Medical Journal·B N PRICHARD
Jan 1, 1965·Annual Review of Pharmacology·A L BOURA, A F GREEN
Mar 15, 1948·The Journal of Physiology·E BülbringF J De Elio
Jun 1, 1948·The American Journal of Physiology·R P AHLQUIST


Feb 1, 1991·Naunyn-Schmiedeberg's Archives of Pharmacology·J Abrahamsen, O A Nedergaard
Sep 1, 1988·The Journal of Pharmacy and Pharmacology·N el TayarA J Kaumann
Oct 12, 2018·The Journal of Physiology·Emma N Bardsley, David J Paterson
Jan 1, 1988·Pharmacology & Toxicology·O A Nedergaard
Aug 1, 1987·Naunyn-Schmiedeberg's Archives of Pharmacology·O A Nedergaard
Jan 1, 1992·Clinical and Experimental Hypertension. Part A, Theory and Practice·D C Eikenburg
Oct 1, 1996·Journal of Autonomic Pharmacology·A EncaboG Balfagón
Jan 1, 1989·Clinical and Experimental Hypertension. Part A, Theory and Practice·P C ChangP van Brummelen
Oct 1, 1990·Pharmacology & Toxicology·J Abrahamsen, O A Nedergaard
Mar 10, 1999·The American Journal of Physiology·J R de HaasJ Zaagsma
Jan 1, 1988·Pharmacology & Toxicology·J Abrahamsen, O A Nedergaard
Dec 1, 1989·Clinical and Experimental Pharmacology & Physiology·M A MianM J Rand
Jan 1, 1990·Annals of the New York Academy of Sciences·O A Nedergaard, J Abrahamsen
Dec 6, 2001·The Japanese Journal of Physiology·K MatsukawaK Shimizu
Aug 30, 2002·Neurotoxicology and Teratology·Y MisuKiyohide Fujita
Sep 1, 1995·Neuroscience Research·Y MisuY Goshima

Related Concepts

Cyclic AMP, (R)-Isomer
Adrenergic beta-Antagonists
Feedback - System Communication
Hypertensive Disease
Nerve Endings
Synaptic Transmission
Beta-adrenergic receptor
Synaptic Receptors

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.